File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Odontogenic differentiation of dental pulp stem cells by glycogen synthase kinase-3β inhibitory peptides

TitleOdontogenic differentiation of dental pulp stem cells by glycogen synthase kinase-3β inhibitory peptides
Authors
KeywordsDental pulp stem cells
GSK inhibitors
Peptides
Wnt signaling
Issue Date4-Feb-2025
PublisherBioMed Central
Citation
Stem Cell Research and Therapy, 2025, v. 16, n. 1 How to Cite?
AbstractBackground: To investigate the effects of peptide-based substrate competitive inhibitors of GSK-3β (GSK-3βi) on promoting odontogenic differentiation of human dental pulp stem cells (hDPSCs). Methods: The biocompatibility and proliferation of hDPSCs treated with GSK-3βi peptides (pS9, LRP 6a, L803, and L803-mts) were evaluated using the tetrazolium reduction assay and cell counting kit-8 assay, respectively. The differentiation of hDPSCs following peptide treatment was determined using the alkaline phosphatase assay (ALP), calcium mineralization (alizarin red staining), and quantification of mRNA expression of differentiation markers via quantitative real-time polymerase chain reaction. The accumulation of β-catenin in the nucleus of GSK3-βi-treated hDPSCs was determined using immunofluorescence staining. The effect of peptide treatment on hDPSC migration was characterized using the transwell assay. Results: All tested concentrations of the peptides were found to be biocompatible with the hDPSCs, with no significant difference compared to the control (p > 0.05). The peptides had no effect on the proliferation of hDPSCs compared to the control (p > 0.05). However, all the tested peptides significantly increased ALP activity and calcium deposition in a dose-dependent manner (p < 0.05). Specifically, L803-mts showed significantly greater ALP activity and mineralization compared to the other peptides and the controls (p < 0.05). Additionally, L803-mts showed a significant increase (p < 0.05) in the expression of DSPP, DMP-1, Runx-2, along with increased protein expression of DSPP and DMP-1 compared to the control. Furthermore, it enhanced the nuclear translocation of β-catenin and increased the chemotactic migratory potential of hDPSCs. Conclusions: L803-mts, a peptide-based substrate competitive inhibitor of GSK-3β, enhanced the odontogenic differentiation of hDPSCs by activating the Wnt signaling pathway.
Persistent Identifierhttp://hdl.handle.net/10722/358505
ISSN
2023 Impact Factor: 7.1
2023 SCImago Journal Rankings: 1.798
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorRajasekar, V-
dc.contributor.authorAbdalla, MM-
dc.contributor.authorBasbrain, MS-
dc.contributor.authorNeelakantan, P-
dc.contributor.authorYiu, CKY-
dc.date.accessioned2025-08-07T00:32:43Z-
dc.date.available2025-08-07T00:32:43Z-
dc.date.issued2025-02-04-
dc.identifier.citationStem Cell Research and Therapy, 2025, v. 16, n. 1-
dc.identifier.issn1757-6512-
dc.identifier.urihttp://hdl.handle.net/10722/358505-
dc.description.abstractBackground: To investigate the effects of peptide-based substrate competitive inhibitors of GSK-3β (GSK-3βi) on promoting odontogenic differentiation of human dental pulp stem cells (hDPSCs). Methods: The biocompatibility and proliferation of hDPSCs treated with GSK-3βi peptides (pS9, LRP 6a, L803, and L803-mts) were evaluated using the tetrazolium reduction assay and cell counting kit-8 assay, respectively. The differentiation of hDPSCs following peptide treatment was determined using the alkaline phosphatase assay (ALP), calcium mineralization (alizarin red staining), and quantification of mRNA expression of differentiation markers via quantitative real-time polymerase chain reaction. The accumulation of β-catenin in the nucleus of GSK3-βi-treated hDPSCs was determined using immunofluorescence staining. The effect of peptide treatment on hDPSC migration was characterized using the transwell assay. Results: All tested concentrations of the peptides were found to be biocompatible with the hDPSCs, with no significant difference compared to the control (p > 0.05). The peptides had no effect on the proliferation of hDPSCs compared to the control (p > 0.05). However, all the tested peptides significantly increased ALP activity and calcium deposition in a dose-dependent manner (p < 0.05). Specifically, L803-mts showed significantly greater ALP activity and mineralization compared to the other peptides and the controls (p < 0.05). Additionally, L803-mts showed a significant increase (p < 0.05) in the expression of DSPP, DMP-1, Runx-2, along with increased protein expression of DSPP and DMP-1 compared to the control. Furthermore, it enhanced the nuclear translocation of β-catenin and increased the chemotactic migratory potential of hDPSCs. Conclusions: L803-mts, a peptide-based substrate competitive inhibitor of GSK-3β, enhanced the odontogenic differentiation of hDPSCs by activating the Wnt signaling pathway.-
dc.languageeng-
dc.publisherBioMed Central-
dc.relation.ispartofStem Cell Research and Therapy-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectDental pulp stem cells-
dc.subjectGSK inhibitors-
dc.subjectPeptides-
dc.subjectWnt signaling-
dc.titleOdontogenic differentiation of dental pulp stem cells by glycogen synthase kinase-3β inhibitory peptides-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1186/s13287-025-04150-7-
dc.identifier.scopuseid_2-s2.0-85217877685-
dc.identifier.volume16-
dc.identifier.issue1-
dc.identifier.eissn1757-6512-
dc.identifier.isiWOS:001413819400005-
dc.identifier.issnl1757-6512-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats